TW201831676A - Method and apparatus both for producing cell aggregate structure - Google Patents

Method and apparatus both for producing cell aggregate structure Download PDF

Info

Publication number
TW201831676A
TW201831676A TW106136724A TW106136724A TW201831676A TW 201831676 A TW201831676 A TW 201831676A TW 106136724 A TW106136724 A TW 106136724A TW 106136724 A TW106136724 A TW 106136724A TW 201831676 A TW201831676 A TW 201831676A
Authority
TW
Taiwan
Prior art keywords
cell
pin
culture
aggregate
cells
Prior art date
Application number
TW106136724A
Other languages
Chinese (zh)
Inventor
米田健二
越田一朗
Original Assignee
日商澁谷工業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商澁谷工業股份有限公司 filed Critical 日商澁谷工業股份有限公司
Publication of TW201831676A publication Critical patent/TW201831676A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00Tissue, human, animal or plant cell, or virus culture apparatus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

A method for producing a cell aggregate structure comprises: a supply step of holding a cell agglutinate clump 2 on a holding section H composed of multiple pins 16 that are provided so as to stand in a culture vessel 3; a culturing step of culturing the cell agglutinate clump 2 held on the holding section H to form a cell aggregate structure (an adhesion pad 4); a detachment step of detaching the adhesion pad 4 formed in the culturing step from the holding section H; and an injection step of injecting an injectant into the adhesion pad 4 detached in the detachment step through through-holes 4a that are formed by the pins 16 and open into the adhesion pad 4. It becomes possible to produce a cell aggregate structure having a desired shape and a desired dimension.

Description

細胞之集合結構體之製作方法及製作裝置  Method for producing aggregate structure of cells and manufacturing device  

本發明係關於一種細胞之集合結構體之製作方法及製作裝置,詳細而言係關於一種將多個細胞凝集塊配置於收容有培養液之培養容器之內部,培養上述多個細胞凝集塊,而製作由上述多個細胞凝集塊相互融合而成之細胞之集合結構體的細胞之集合結構體之製作方法及製作裝置。 The present invention relates to a method and apparatus for producing a collection structure of cells, and more particularly to a method of arranging a plurality of cell aggregates in a culture container in which a culture solution is accommodated, and culturing the plurality of cell aggregates. A method and apparatus for producing a collection structure of cells of a collection structure of cells in which a plurality of cell aggregates are fused to each other.

於利用幹細胞等使受到損傷之生物功能恢復之再生醫療中,使用高密度培養有細胞之細胞片。該細胞片極薄,故而已知有將多張細胞片重疊之積層化培養細胞片之製造方法(專利文獻1)。 In a regenerative medicine that restores the function of a damaged organism using stem cells or the like, a cell sheet in which cells are cultured at a high density is used. Since the cell sheet is extremely thin, a method for producing a laminated cultured cell sheet in which a plurality of cell sheets are superposed is known (Patent Document 1).

又,於此種將細胞片重疊之積層化培養細胞片之製造方法中,亦已知有如下方法:於所要積層之細胞片與細胞片之間配置水凝膠粒子,使氧或營養等遍佈積層部分之細胞,更確實地製造細胞片(專利文獻2)。 Further, in the method for producing a laminated cultured cell sheet in which the cell sheets are superposed, a method is also known in which a hydrogel particle is placed between the cell sheet to be laminated and the cell sheet to spread oxygen or nutrients. The cells in the layered portion are more reliably produced into a cell sheet (Patent Document 2).

另一方面,亦已知有如下製作方法:預先將細胞培養成大致球狀,形成細胞凝集塊(球狀細胞塊,spheroid),將該細胞凝集塊以相互接觸之狀態排列而進行浮游培養,製作由細胞凝集塊彼此融合而成、具有50~300μm之厚度的片狀細胞凝集塊(專利文獻3)。 On the other hand, a method is also known in which a cell is cultured into a substantially spherical shape to form a cell agglutination block (spheroid), and the cell aggregates are arranged in contact with each other to perform phytoplankton culture. A sheet cell aggregate having a thickness of 50 to 300 μm which is fused by a cell aggregate is prepared (Patent Document 3).

[先前技術文獻] [Previous Technical Literature]

[專利文獻] [Patent Literature]

[專利文獻1]日本專利第4921353號公報 [Patent Document 1] Japanese Patent No. 4921353

[專利文獻2]日本專利第5862915號公報 [Patent Document 2] Japanese Patent No. 5629915

[專利文獻3]日本專利第5523830號公報 [Patent Document 3] Japanese Patent No. 5523830

然而,如專利文獻1、2般將細胞片積層化之情形時,由於細胞片極薄,故而有難以處理,難以使之自動化的問題;又,如專利文獻3般浮游培養細胞凝集塊而希望獲得片狀細胞凝集塊之情形時,由於整齊排列之細胞凝集塊之間疏密不均,細胞凝集塊彼此會不規則地融合,故而有所獲得之片狀細胞凝集塊之形狀不固定,厚度亦不均勻的問題。 However, when the cell sheet is laminated as in the case of the patent documents 1 and 2, since the cell sheet is extremely thin, it is difficult to handle and it is difficult to automate it. Further, as in Patent Document 3, it is desirable to float the cell agglutination block and hope When the agglomerate of the sheet-like cells is obtained, the cell agglomerates are irregularly fused with each other due to uneven density between the cells arranged in a neat arrangement, so that the shape of the obtained agglomerate of the sheet-like cells is not fixed, and the thickness is not fixed. Also uneven.

鑒於上述問題,本發明提供一種能夠獲得所需之形狀及尺寸,且能夠增加功能性,又對應自動化的細胞之集合結構體之製作方法及製作裝置。 In view of the above problems, the present invention provides a method and apparatus for producing a collective structure of cells capable of obtaining a desired shape and size and capable of increasing functionality, and corresponding to automation.

即,請求項1之發明之細胞之集合結構體之製作方法將多個細胞凝集塊配置於收容有培養液之培養容器之內部,培養上述多個細胞凝集塊,而製作由上述多個細胞凝集塊相互融合而成的細胞之集合結構體;且其特徵在於具有:供給步驟,其使由豎立設置於上述培養容器之內部之多個銷所構成的保持部保持細胞凝集塊;培養步驟,其培養保持於上述保持部之細胞凝集塊而形成上述集合結構體;脫離步驟,其將於該培養步驟中形成之集合結構體自上述保持部取出;及注入步驟,其將注入物注入開設於該脫離步驟中所取出之集合結構體之藉由上述銷而形成的貫通孔。 In the method of producing the aggregate structure of the cell of the invention of claim 1, the plurality of cell aggregates are placed in a culture container in which the culture solution is accommodated, and the plurality of cell aggregates are cultured to produce a plurality of cells agglutinated. a collection structure of cells in which the blocks are fused together, and characterized in that: a supply step of holding a cell aggregate by a holding portion composed of a plurality of pins erected inside the culture container; and a culturing step And cultivating the aggregated cells held in the holding portion to form the aggregate structure; the detaching step of taking out the aggregate structure formed in the culturing step from the holding portion; and the injecting step of injecting the implant into the set The through hole formed by the pin is removed from the aggregate structure taken out in the step.

又,請求項3之發明之細胞之集合結構體之製作裝置將多個細胞凝集塊配置於收容有培養液之培養容器之內部,培養上述多個細胞凝集塊,而 製作由上述多個細胞凝集塊相互融合而成的細胞之集合結構體;且其特徵在於具備:培養保持器,其設置於上述培養容器之內部,且豎立設置有多個銷;供給手段,其使由上述培養保持器之銷所構成之多個保持部保持細胞凝集塊;脫離手段,其將對保持於上述培養保持器之細胞凝集塊加以培養而形成之集合結構體自上述培養保持器之上述保持部取出;及注入手段,其將注入物注入開設於該已取出之集合結構體之藉由上述銷而形成的貫通孔。 Further, in the apparatus for producing a collection structure of cells according to the invention of claim 3, a plurality of cell aggregates are placed in a culture container containing the culture solution, and the plurality of cell aggregates are cultured to produce a plurality of cells agglutinated. a collection structure of cells in which the blocks are fused together, and characterized in that: a culture holder provided inside the culture container and provided with a plurality of pins erected; and a supply means for the culture holder a plurality of holding portions formed by the pins hold the cell aggregates; and a separating means for taking out the aggregate structure formed by culturing the cell aggregates held in the culture holder from the holding portion of the culture holder; and injecting And means for injecting the injection into the through hole formed by the pin formed in the extracted aggregate structure.

根據上述請求項1及請求項3之發明,將設置於上述培養保持器之多個銷與銷之間作為保持部,而藉由多個鄰接之保持部保持細胞凝集塊,故而各細胞凝集塊藉由於該保持部接受培養而相互融合,從而可製作所需之形狀及尺寸之細胞之集合結構體,且可將其自動化。 According to the inventions of claim 1 and claim 3, the plurality of pins and the pins provided in the culture holder are used as the holding portions, and the cell agglomerates are held by the plurality of adjacent holding portions, so that the cells are aggregated. By merging the holding portions in a culture, it is possible to produce a collection structure of cells of a desired shape and size, and to automate them.

進而,於如此培養所得之細胞之集合結構體,藉由構成上述保持部之銷而形成有貫通孔,故而藉由將注入物注入該貫通孔,可製作增加了功能性之細胞之集合結構體。 Further, in the aggregate structure of the cells thus obtained, the through-holes are formed by the pins constituting the holding portion, so that the injection structure can be injected into the through-holes, whereby the aggregate structure of the cells having increased functionality can be produced. .

1‧‧‧細胞之集合結構體之製作裝置 1‧‧‧Financial collection device

2‧‧‧細胞凝集塊 2‧‧‧cell agglutination

3‧‧‧培養容器 3‧‧‧ culture container

4‧‧‧癒合墊(細胞之集合結構體) 4‧‧‧healing pad (collective structure of cells)

10‧‧‧抽吸嘴 10‧‧‧ suction nozzle

12‧‧‧注入嘴 12‧‧‧Injection

16‧‧‧銷 16‧‧ ‧ sales

17‧‧‧支持板 17‧‧‧Support board

g‧‧‧間隙 G‧‧‧ gap

H‧‧‧保持部 H‧‧‧Holding Department

圖1係設置細胞之集合結構體之製造裝置的隔離器與培養箱之前視圖。 Fig. 1 is a front view of an isolator and an incubator of a manufacturing apparatus for setting a collection structure of cells.

圖2係細胞之集合結構體之製造裝置之構成圖。 Fig. 2 is a configuration diagram of a manufacturing apparatus for a collection structure of cells.

圖3係收容容器及抽吸嘴之剖視圖。 Figure 3 is a cross-sectional view of the storage container and the suction nozzle.

圖4係培養容器之剖視圖。 Figure 4 is a cross-sectional view of the culture vessel.

圖5係配置於培養容器內之細胞凝集塊之俯視圖。 Fig. 5 is a plan view of a cell aggregate disposed in a culture container.

圖6係注入嘴之剖視圖,且係說明將注入物注入細胞之集合結構體之貫通孔 之注入步驟的圖。 Fig. 6 is a cross-sectional view of the injection nozzle, and is a view illustrating a step of injecting the injection into the through hole of the aggregate structure of the cells.

圖7係說明構成第2實施例中之第1、第2銷群之銷之配置的圖。 Fig. 7 is a view for explaining the arrangement of pins constituting the first and second pin groups in the second embodiment.

圖8係表示第2實施例中之培養狀態之圖。 Fig. 8 is a view showing the state of culture in the second embodiment.

圖9係表示第3實施例中之培養狀態之圖。 Fig. 9 is a view showing the state of culture in the third embodiment.

圖10係第3實施例中配置於培養容器內之細胞凝集塊之俯視圖。 Fig. 10 is a plan view showing a cell aggregate in a culture container in the third embodiment.

圖11係表示第4實施例中之培養狀態之圖。 Fig. 11 is a view showing the state of culture in the fourth embodiment.

圖12係表示第5實施例中之培養狀態之圖。 Fig. 12 is a view showing the state of culture in the fifth embodiment.

圖13係對銷之粗細與細胞凝集塊之大小進行說明之圖。 Fig. 13 is a view for explaining the thickness of the pin and the size of the cell aggregate.

以下,對圖示實施例進行說明,圖1~圖6係說明第1實施例之細胞之集合結構體之製作裝置1的圖,該等圖表示將多個細胞凝集塊2(球狀細胞塊:參照圖3)配置於培養容器3之內部,培養上述細胞凝集塊2,而製作由上述細胞凝集塊2相互融合而成、作為細胞之集合結構體之癒合墊4(參照圖4)。 Hereinafter, the illustrated embodiment will be described, and FIGS. 1 to 6 are views showing the apparatus 1 for producing a cell assembly according to the first embodiment, which shows a plurality of cell agglutination blocks 2 (spheroid cell blocks). With reference to Fig. 3), the cell agglutination block 2 is placed in the inside of the culture container 3, and a healing pad 4 (see Fig. 4) which is a collection structure of cells formed by merging the cell aggregates 2 is prepared.

上述細胞凝集塊2例如可利用日本專利第4517125號公報中所揭示之方法製作。即,將細胞播種於內表面為非接著性之容器內加以培養,細胞找到立足點後相互接著,由此凝集而形成細胞凝集塊2,該等進而融合,而形成外徑尺寸為500μm左右之大致球狀之細胞凝集塊2。 The cell aggregate 2 can be produced, for example, by the method disclosed in Japanese Patent No. 4517125. That is, the cells are sown in a container in which the inner surface is non-adhesive, and the cells find a foothold and then follow each other, thereby agglutinating to form a cell aggregate 2, which is further fused to form an outer diameter of about 500 μm. A substantially spherical cell aggregate 2 .

就更有效率而言,利用孔培養板之非接著性之孔(大致半球狀之收容部)進行培養,藉此可容易地獲得細胞凝集塊2。再者,細胞凝集塊2之製作方法並不限定於此,而可利用公知之各種方法製作,例如:於旋轉之培養液中加入細胞懸濁液之旋轉培養法、於試驗管中加入細胞懸濁液利用離心分離器使之沈澱之方法、或者使用海藻酸顆粒進行培養之方法等。 More efficiently, the cells are cultured by non-adhesive pores (substantially hemispherical accommodating portions) of the well culture plate, whereby the cell aggregate 2 can be easily obtained. Further, the method for producing the cell aggregate 2 is not limited thereto, and can be produced by various known methods, for example, a spin culture method in which a cell suspension is added to a rotating culture solution, and a cell suspension is added to the test tube. A method in which a turbid liquid is precipitated by a centrifugal separator or a method of culturing using alginic acid granules.

綜上,所謂細胞凝集塊2係指細胞彼此集合並凝集化而成、具有100~700μm 左右之外徑尺寸之大致球狀之細胞集合體,若使該等細胞凝集塊2平面性地或立體性地接觸或接近而配置,則各細胞凝集塊2之細胞增生而與鄰接之細胞凝集塊2融合,從而可獲得平面性或立體性之細胞之集合結構體。 In summary, the cell agglutination block 2 is a substantially spherical cell aggregate having an outer diameter of about 100 to 700 μm formed by aggregating and aggregating cells, and the cell agglomerates 2 are planar or three-dimensional. When it is placed in contact or close to each other, the cells of each cell aggregate 2 are proliferated and fused with the adjacent cell agglutination block 2, whereby a planar or stereoscopic cell aggregate structure can be obtained.

本實施例中所製作之癒合墊4係由例如骨骼、肌肉、內臟、血管、皮膚等之組織、或者構成臟器、器官之體細胞或其前驅細胞、幹細胞等製成,填補骨骼或軟骨之缺損部,或貼附於臟器或器官之表面而使用。 The healing pad 4 produced in the present embodiment is made of a tissue such as bone, muscle, viscera, blood vessel, skin, or somatic cells, organs or precursor cells thereof, stem cells, etc., which fills bones or cartilage. Use the defect or attach it to the surface of an organ or organ.

又,上述癒合墊4係將多個細胞凝集塊2平面性地配置並使之融合而成,其厚度可根據所使用之細胞凝集塊2之尺寸製作成100~700μm左右,其平面尺寸可根據整齊排列之細胞凝集塊2之個數而調節。 Further, the healing pad 4 is formed by arranging and condensing a plurality of cell aggregates 2 in a planar manner, and the thickness thereof can be made to be about 100 to 700 μm depending on the size of the cell aggregate 2 to be used, and the planar size can be determined according to The number of cell agglutination blocks 2 arranged neatly is adjusted.

如此製作之上述癒合墊4與藉由平面性地培養細胞懸濁液來將細胞單體培養成片狀而獲得之細胞片不同。 The above-described healing pad 4 thus produced is different from a cell sheet obtained by culturing a cell suspension in a planar manner to culture a cell monomer into a sheet.

本實施例之細胞之集合結構體之製作裝置1設置於圖1所示之內部維持為無菌狀態之隔離器5之內部、及以能夠與該隔離器5連接之方式設置之培養箱6之內部。又,於隔離器5設置有用以去除搬入物污染之傳遞窗(pass box)5a。 The apparatus 1 for producing a collective structure of cells of the present embodiment is provided inside the isolator 5 which is maintained in an aseptic state as shown in Fig. 1, and inside the incubator 6 which is connectable to the isolator 5 . Further, a pass box 5a for removing the contamination of the carry-in is provided in the isolator 5.

圖2係表示設置於上述隔離器5之內部之構成,其具備:收容容器支持部8,其支持收容細胞凝集塊2之收容容器7;培養容器支持部9,其支持培養癒合墊4之培養容器3;多個抽吸嘴10,其等保持上述細胞凝集塊2;抽吸嘴移動手段11,其使上述抽吸嘴10相對於上述收容容器7及培養容器3相對性地移動;作為注入手段之注入嘴12,其將注入物注入所培養之癒合墊4;及注入嘴移動手段13,其使上述注入嘴12相對於上述培養容器3相對性地移動。 2 is a view showing a configuration provided inside the isolator 5, and includes a storage container support portion 8 that supports a storage container 7 that houses the cell aggregate 2; and a culture container support portion 9 that supports cultivation of the culture healing pad 4. a container 3; a plurality of suction nozzles 10, which hold the cell aggregate 2; and a suction nozzle moving means 11 for relatively moving the suction nozzle 10 with respect to the storage container 7 and the culture container 3; The injection nozzle 12 of the means injects the injection into the cultured healing pad 4; and the injection nozzle moving means 13 which relatively moves the injection nozzle 12 relative to the culture container 3.

再者,於以下之說明中,圖2中將圖示左右方向設為X方向,將前後方向設為Y方向,將上下方向設為Z方向,圖5中將圖示左右方向設為X方向,將上下方向設為Y方向。 In the following description, in FIG. 2, the left-right direction is shown as the X direction, the front-rear direction is the Y direction, and the vertical direction is the Z direction. In FIG. 5, the left-right direction is shown as the X direction. , set the up and down direction to the Y direction.

上述隔離器5係內部被維持為無菌環境,又會藉由無菌空氣供給 手段而形成自上方朝下方之單向無菌空氣氣流。 The isolator 5 is internally maintained in a sterile environment and is formed by a sterile air supply means to form a unidirectional sterile air stream from above.

又,於隔離器5之正面設置有可供作業員佩戴之手套5b,從而能夠進行各種作業。再者,亦可於隔離器5之內部設置機器人或具有所需構成之移送手段,從而使該等作業自動進行。 Further, a glove 5b that can be worn by an operator is provided on the front surface of the isolator 5, so that various operations can be performed. Further, a robot or a transfer means having a desired configuration may be provided inside the isolator 5 to automatically perform the operations.

其次,上述培養箱6係內部維持為無菌環境,並且維持為適於培養癒合墊4之特定之溫度及濕度,又於細胞凝集塊2融合而朝癒合墊4形成之期間,能夠使上述培養箱6自上述隔離器5分離,而載置於與該隔離器5相離之位置。 Next, the inside of the incubator 6 is maintained in a sterile environment and maintained at a specific temperature and humidity suitable for culturing the healing pad 4, and the cell can be made while the cell agglutination block 2 is fused to form the healing pad 4. 6 is separated from the isolator 5 and placed at a position away from the isolator 5.

因此,上述隔離器5與培養箱6係藉由連接手段5c而連接,例如可使用如日本專利第4656485號公報中所記載下述連接手段:使培養箱6與隔離器5維持無菌狀態而相接/分離。 Therefore, the isolator 5 and the incubator 6 are connected by the connecting means 5c. For example, the following connecting means as described in Japanese Patent No. 4654648 can be used to maintain the incubator 6 and the isolator 5 in a sterile state. Connect/separate.

圖3係表示上述收容容器7之剖視圖,該收容容器7可使用上述孔培養板。收容容器7於俯視下縱橫地具備多個收容凹部7a,各收容凹部7a之內部收容有培養液且各收容有一個大致球狀之細胞凝集塊2。 Fig. 3 is a cross-sectional view showing the above-described storage container 7, in which the above-mentioned hole culture plate can be used. The storage container 7 is provided with a plurality of housing recesses 7a in a vertical direction and a horizontal direction in plan view, and each of the housing recesses 7a accommodates a culture solution and accommodates a substantially spherical cell aggregate 2 therein.

上述收容容器7之收容凹部7a於俯視下之X方向及Y方向分別各整齊排列有特定個數個,於本實施例中,構成於培養容器3中製作之癒合墊4之細胞凝集塊2的X方向與Y方向之個數相同,即,分別於X方向設置有5個,於Y方向設置有5個。 The storage recessed portion 7a of the storage container 7 is arranged in a predetermined number in the X direction and the Y direction in the plan view. In the present embodiment, the cell agglutination block 2 of the healing pad 4 produced in the culture container 3 is formed. The number of the X direction and the Y direction are the same, that is, five in the X direction and five in the Y direction.

支持上述收容容器7之收容容器支持部8係藉由定位片8b將上述收容容器7定位於其上表面,並且由構成上述抽吸嘴移動手段11之Y方向平台8a所構成。 The storage container support portion 8 that supports the storage container 7 is configured by positioning the storage container 7 on the upper surface thereof by the positioning piece 8b, and is constituted by the Y-direction platform 8a constituting the suction nozzle moving means 11.

如下所述,本實施例之抽吸嘴10於X方向設置有5個,又僅能於X方向及Z方向移動,故而藉由上述Y方向平台8a使收容容器7於Y方向移動,可使抽吸嘴10與收容容器7於XYZ各個方向相對性地移動。 As described below, the suction nozzle 10 of the present embodiment is provided in five in the X direction, and can be moved only in the X direction and the Z direction. Therefore, the storage container 7 can be moved in the Y direction by the Y direction platform 8a. The suction nozzle 10 and the storage container 7 are relatively moved in various directions of XYZ.

若具體地進行說明,即,首先上述Y方向平台8a使收容容器7之第1行收容凹 部7a位於抽吸嘴10之下方,若抽吸嘴10自該第一行收容凹部7a吸附保持細胞凝集塊2,則Y方向平台8a使收容容器7於Y方向僅移動1行收容凹部7a的距離,使第2行收容凹部7a位於抽吸嘴10之下方。 Specifically, first, the Y-direction stage 8a is such that the first row housing recess 7a of the storage container 7 is positioned below the suction nozzle 10, and if the suction nozzle 10 is sucked from the first row housing recess 7a, the cell aggregation is maintained. In the block 2, the Y-direction platform 8a moves the storage container 7 by only one row of the housing recess 7a in the Y direction, and the second row housing recess 7a is positioned below the suction nozzle 10.

如圖4所示,培養容器3為有底箱狀,於內部以特定深度收容培養液,並且設置有:底面板14,其設置於底面;培養保持器,其由設置於該底面板14之台座15及豎立設置於該台座15之多個銷16所構成;及作為支持構件之支持板17,其沿著上述銷16而上下移動。 As shown in FIG. 4, the culture container 3 has a bottomed box shape, and accommodates the culture liquid at a specific depth inside, and is provided with a bottom panel 14 which is disposed on the bottom surface, and a culture holder which is disposed on the bottom panel 14 The pedestal 15 and the plurality of pins 16 that are erected on the pedestal 15 are formed; and the support plate 17 as a support member moves up and down along the pin 16.

上述底面板14具有與培養容器3之底面大致相同之形狀,且係以底面板14不於培養容器3之內部移動的方式定位。又,上述台座15具有長方體形狀,且係與形成於底面板14之上表面之凹部14a嵌合而定位。 The bottom panel 14 has substantially the same shape as the bottom surface of the culture container 3, and is positioned such that the bottom panel 14 does not move inside the culture container 3. Further, the pedestal 15 has a rectangular parallelepiped shape and is fitted to the concave portion 14a formed on the upper surface of the bottom panel 14 to be positioned.

上述銷16以分別朝向Z方向之方式規則地豎立設置在形成於上述台座15之上表面之設置面15a。 The pins 16 are regularly erected on the installation surface 15a formed on the upper surface of the pedestal 15 so as to face the Z direction.

圖5係表示設置於上述台座15之銷16與藉由該銷16而保持之細胞凝集塊2之俯視圖,本實施例中,於X方向及Y方向分別有5個細胞凝集塊2以相互接觸之狀態平面性地整齊排列。 5 is a plan view showing the pin 16 provided on the pedestal 15 and the cell aggregate 2 held by the pin 16. In the present embodiment, there are five cell aggregates 2 in the X direction and the Y direction to contact each other. The states are arranged neatly in a planar manner.

上述銷16係以位於各細胞凝集塊2之周圍之方式設置,於本實施例中,由4根銷16構成保持細胞凝集塊2之保持部H。更具體而言,將俯視下4根銷16位於四角之大致正方形之區塊設為上述保持部H。 The pin 16 is provided so as to be located around each cell agglutination block 2. In the present embodiment, the four pins 16 constitute a holding portion H for holding the cell aggregate 2 . More specifically, the block in which the four pins 16 are located at substantially four squares in plan view is referred to as the above-described holding portion H.

於本實施例中,以構成上述保持部H之4根銷16中各對角位置之2根銷16之間隔短於其等所保持之細胞凝集塊2之直徑的方式進行配置。換言之,於製作細胞凝集塊2時,要使其直徑大於各對角位置之2根銷16之間隔。 In the present embodiment, the interval between the two pins 16 at the respective diagonal positions of the four pins 16 constituting the holding portion H is arranged to be shorter than the diameter of the cell aggregate 2 held by the same. In other words, when the cell aggregate 2 is produced, the diameter is made larger than the interval between the two pins 16 at the respective diagonal positions.

若由如此構成之保持部H保持細胞凝集塊2,則可將細胞凝集塊2夾持於多個銷16與銷16之間,且能夠如圖4(a)般使細胞凝集塊2位於上述銷16之頂端與根部之間的上下中間部分。 When the cell agglutination block 2 is held by the holding portion H thus constituted, the cell aggregate block 2 can be sandwiched between the plurality of pins 16 and the pin 16, and the cell aggregate 2 can be placed as described above in Fig. 4(a). The upper and lower intermediate portions between the top end of the pin 16 and the root.

換言之,可將上述保持部H設定於與豎立設置有上述多個銷16之設置面15a離隔之位置,且可在保持於該保持部H之細胞凝集塊2與設置面15a之間形成可供培養液流通之間隙g。 In other words, the holding portion H can be set at a position apart from the installation surface 15a on which the plurality of pins 16 are erected, and can be formed between the cell aggregate 2 and the installation surface 15a held by the holding portion H. The gap g between the culture fluids.

又,藉由使各對角位置之2根銷16之間隔短於細胞凝集塊2之直徑,可將各保持部H之細胞凝集塊2以彼此相互接觸之狀態加以培養,但亦取決於銷16之直徑。 Further, by making the interval between the two pins 16 at the respective diagonal positions shorter than the diameter of the cell aggregate 2, the cell aggregates 2 of the respective holding portions H can be cultured in contact with each other, but also depending on the pin. 16 diameter.

於上述底面板14以下述方式設置有2根棒狀之引導構件18,即,設置於隔著上述台座15而對向之位置,並且朝向Z方向豎立設置而上下貫通上述支持板17;於上述支持板17穿設有供上述銷16貫通之貫通孔17a。 The bottom panel 14 is provided with two rod-shaped guide members 18 disposed at positions facing each other across the pedestal 15 and erected in the Z direction to vertically penetrate the support plate 17; The support plate 17 is provided with a through hole 17a through which the pin 16 passes.

根據上述構成,上述支持板17係設置為能夠沿著上述銷16及引導構件18於Z方向升降,並且通常由於自體重量而位於下述下降位置,該下降位置係成為載置於上述台座15之設置面15a之銷16之基端側的位置。 According to the above configuration, the support plate 17 is provided so as to be movable up and down along the pin 16 and the guide member 18 in the Z direction, and is normally placed at a lowering position by the weight of the body, and the lowered position is placed on the pedestal 15 The position of the base end side of the pin 16 of the setting surface 15a.

於圖4(a)所示之支持板17位於下降位置時,保持於上述銷16之上下中間部分之細胞凝集塊2與上述台座15之設置面15a之間會形成可供培養液流通之間隙g。 When the support plate 17 shown in FIG. 4(a) is in the lowered position, a gap between the cell agglomerate 2 held in the lower middle portion of the pin 16 and the installation surface 15a of the pedestal 15 forms a gap for the culture liquid to flow. g.

另一方面,如圖4(b)所示,若使支持板17上升,則支持板17可自下方支持保持於上述銷16與銷16之間之細胞凝集塊2,藉由使上述支持板17位於成為銷16之頂端側之上升位置,可將培養細胞凝集塊2而成之癒合墊4自上述銷16之間之保持部H取出。 On the other hand, as shown in FIG. 4(b), when the support plate 17 is raised, the support plate 17 can support the cell aggregate 2 held between the pin 16 and the pin 16 from below by the support plate. 17 is located at a rising position on the distal end side of the pin 16, and the healing pad 4 in which the cell aggregate 2 is cultured can be taken out from the holding portion H between the pins 16.

上述支持板17之上升除了可由配戴有手套5b之作業員進行以外,亦可由機器人等進行。此時,雖未圖示,但藉由於上述支持板17之上表面設置自上述培養液之液面向上方突出之固持構件,能夠不接觸培養液地使支持板17上升。 The rise of the above-described support plate 17 can be performed by a robot or the like in addition to the worker wearing the glove 5b. In this case, although the holding member that protrudes upward from the liquid surface of the culture liquid is provided on the upper surface of the support plate 17, the support plate 17 can be raised without contacting the culture liquid.

如圖2所示,培養容器支持部9係由構成上述抽吸嘴移動手段11之Y方向平台9a所構成,與構成上述收容容器支持部8之Y方向平台8a相同,每當 將吸附保持於抽吸嘴10之細胞凝集塊2供給至由上述銷16所構成之保持部H,便使設定於銷16間之保持部H連同培養容器3一起於上述Y方向一行一行地移動。 As shown in Fig. 2, the culture container support portion 9 is constituted by the Y-direction land 9a constituting the suction nozzle moving means 11, and is held and held in the same manner as the Y-direction platform 8a constituting the storage container support portion 8. The cell agglutination block 2 of the suction nozzle 10 is supplied to the holding portion H constituted by the above-described pin 16, and the holding portion H set between the pins 16 is moved in line with the culture container 3 in the Y direction.

其次,對上述抽吸嘴10進行說明,如圖3所示,其具備連接於未圖示之負壓產生手段之本體部10a,及設置於該本體部10a之下端部之管狀之吸附部10b。 Next, the suction nozzle 10 will be described. As shown in Fig. 3, the suction nozzle 10 includes a main body portion 10a connected to a negative pressure generating means (not shown), and a tubular adsorption portion 10b provided at a lower end portion of the main body portion 10a. .

上述吸附部10b之內徑相較於上述細胞凝集塊2成為小徑,從而於上述收容容器7之收容凹部7a由吸附部10b之頂端吸附保持細胞凝集塊2時,細胞凝集塊2不會被吸至該吸附部10b之內部。 The inner diameter of the adsorption unit 10b is smaller than the diameter of the cell aggregate 2, and when the storage recess 7a of the storage container 7 is adsorbed and held by the tip end of the adsorption unit 10b, the cell aggregate 2 is not The inside of the adsorption portion 10b is sucked.

又,於培養容器3中,使上述吸附部10b之中心位置位於形成在銷16與銷16之間的保持部H之大致中央,且使細胞凝集塊2位於上述銷16之上下中間位置之狀態下,消除上述負壓產生手段所產生之負壓。 Further, in the culture container 3, the center position of the adsorption portion 10b is located substantially at the center of the holding portion H formed between the pin 16 and the pin 16, and the cell aggregate 2 is placed in the lower middle position of the pin 16 above. Next, the negative pressure generated by the above negative pressure generating means is eliminated.

再者,亦可使用具有藉由夾持器等而保持細胞凝集塊2等之構成者來代替吸附保持細胞凝集塊2之抽吸嘴10來保持細胞凝集塊2。 In addition, a cell agglutination block 2 may be held by using a suction nozzle 10 that has a cell aggregate 2 or the like held by a holder or the like instead of adsorbing and holding the cell aggregate 2 .

又,使上述抽吸嘴10移動之抽吸嘴移動手段11係由如下構件所構成:X方向軌道21,其跨越上述收容容器支持部8及培養容器支持部9而設置於X方向;X方向移動手段22,其使抽吸嘴10沿著該X方向軌道21於X方向移動;Z方向移動手段23,其設置於該X方向移動手段22而使抽吸嘴10於Z方向升降;以及上述收容容器支持部8及培養容器支持部9中之上述Y方向平台8a、9a。再者,作為抽吸嘴移動手段11,亦可具有使上述X方向軌道21於Y方向移動之構成代替Y方向平台8a、9a。藉由形成為此種構成,可使上述抽吸嘴10、注入嘴12、或下述照相機25於X-Y方向移動。 Further, the suction nozzle moving means 11 for moving the suction nozzle 10 is constituted by an X-direction rail 21 which is provided in the X direction across the storage container support portion 8 and the culture container support portion 9; a moving means 22 for moving the suction nozzle 10 in the X direction along the X-direction rail 21; a Z-direction moving means 23 provided in the X-direction moving means 22 for raising and lowering the suction nozzle 10 in the Z direction; The Y-direction platforms 8a and 9a in the container support portion 8 and the culture container support portion 9 are housed. Further, the suction nozzle moving means 11 may have a configuration in which the X-direction rail 21 is moved in the Y direction instead of the Y-direction stages 8a, 9a. With such a configuration, the suction nozzle 10, the injection nozzle 12, or the camera 25 described below can be moved in the X-Y direction.

又,本實施例之抽吸嘴10於X方向整齊排列地設置有5個,該等抽吸嘴10係藉由間隔變更手段24而於X方向變更其間隔。 Further, the suction nozzles 10 of the present embodiment are provided in five rows in the X direction, and the suction nozzles 10 are changed in the X direction by the interval changing means 24.

具體而言,於上述抽吸嘴10位於收容容器支持部8之上方時,間隔變更手段 24將上述抽吸嘴10之間隔變更為與上述收容容器7中之於X方向整齊排列之收容凹部7a相同的間隔。 Specifically, when the suction nozzle 10 is positioned above the storage container support portion 8, the interval changing means 24 changes the interval between the suction nozzles 10 to the accommodation recessed portion 7a aligned with the X direction in the storage container 7. The same interval.

另一方面,於抽吸嘴10位於培養容器支持部9之上方時,間隔變更手段24將抽吸嘴10之間隔變更為與上述培養容器3之內部之形成於銷16與銷16之間的保持部H中之X方向之間隔相同的間隔。 On the other hand, when the suction nozzle 10 is positioned above the culture container support portion 9, the interval changing means 24 changes the interval between the suction nozzles 10 to be formed between the pin 16 and the pin 16 with the inside of the culture container 3. The interval between the X directions in the holding portion H is the same.

再者,抽吸嘴10亦可於Y方向設置有多行,又,於收容容器支持部8之收容凹部7a之間隔與形成於上述銷16與銷16之間的保持部H之間隔相同之情形時,可省略上述間隔變更手段24。 Further, the suction nozzle 10 may be provided in a plurality of rows in the Y direction, and the interval between the housing recesses 7a of the storage container support portion 8 and the holding portion H formed between the pins 16 and the pins 16 are the same. In the case of the above, the interval changing means 24 can be omitted.

又,例如於上述保持部H之間隔狹窄之情形時,亦可藉由上述抽吸嘴10使保持部H每隔一個地保持細胞凝集塊2,於該情形時,只要首先使第奇數號保持部H保持細胞凝集塊2,然後使第偶數號保持部H保持細胞凝集塊2即可。 Further, for example, when the interval between the holding portions H is narrow, the holding portion H may hold the cell aggregate 2 every other time by the suction nozzle 10. In this case, the odd number is first kept. The portion H holds the cell aggregate 2, and then the even-numbered holding portion H is held in the cell aggregate 2.

再者,抽吸嘴10只要具備至少1根即可,又,作為細胞凝集塊2之供給手段,除了如本實施例般移載細胞凝集塊2之構成以外,亦可為將多個細胞凝集塊2一個一個地自收容其之容器陸續送出之構成。 In addition, as long as at least one of the suction nozzles 10 is provided, as a means for supplying the cell aggregate 2, in addition to the configuration in which the cell aggregate 2 is transferred as in the present embodiment, a plurality of cells may be aggregated. Block 2 is constructed one by one from the container in which it is housed.

如圖6所示,上述注入嘴12具備連接於未圖示之注入物供給手段之本體部12a、及設置於該本體部12a之下端部之管狀之注入部12b,如下所述地將注入物注入開設於所培養之癒合墊4之貫通孔4a。 As shown in Fig. 6, the injection nozzle 12 includes a main body portion 12a connected to an injection supply means (not shown), and a tubular injection portion 12b provided at an lower end portion of the main body portion 12a, and the injection material is as described below. The through hole 4a opened in the healing pad 4 to be cultured is injected.

自上述注入物供給手段,以液體、膠、凝膠、粒子、顆粒等狀態供給如下物質作為注入物:促進細胞之培養之營養成分,促進癒合墊4移植至患者之後之生著或成長、周邊組織之再生之成長因子或增生因子,促進血管之新生之細胞懸濁液,作用於移植後之生物之藥物等;其等自上述注入部12b之頂端排出後注入上述癒合墊4之貫通孔4a。再者,注入既可於貫通孔4a之上方進行,亦可將注入嘴12插入至貫通孔4a中進行。 In the above-described infusion product supply means, the following substances are supplied as an infusion in the form of a liquid, a gel, a gel, a particle, or a particle: a nutrient component that promotes the culture of the cell, and promotes the growth or growth of the healing pad 4 after being transplanted to the patient, and the periphery. a growth factor or a proliferative factor of the tissue, a cell suspension for promoting the regeneration of blood vessels, a drug for the living organism after transplantation, etc.; and the like, which is discharged from the tip end of the injection portion 12b and injected into the through hole 4a of the healing pad 4 . Further, the injection may be performed above the through hole 4a, or the injection nozzle 12 may be inserted into the through hole 4a.

藉由如此地注入貫通孔4a,可將注入物埋入至癒合墊4之內部,與將注入物 僅滴至癒合墊4之表面之情形時相比,可使更多注入物浸透至該癒合墊4之內部。 By injecting the through hole 4a in this way, the implant can be buried inside the healing pad 4, and more infusion can be saturated to the healing than when the infusion is dropped only on the surface of the healing pad 4. The inside of the mat 4.

而且,關於注入有上述注入物之癒合墊4,既可繼續培養而堵塞上述貫通孔4a,亦可直接回收而用於移植。 Further, the healing pad 4 to which the infusion material is injected may be cultured to block the through-hole 4a, or may be directly recovered for transplantation.

如圖2所示,注入嘴12於X方向整體排列地設置有4個,具體而言,以成為與沿X方向整齊排列於上述培養容器3之內部之銷16之間隔相同的間隔,即以成為與癒合墊4之貫通孔4a相同之間隔的方式設置。 As shown in FIG. 2, the injection nozzles 12 are integrally arranged in the X direction, and specifically, at the same interval as the interval between the pins 16 arranged in the X direction in the inside of the culture container 3, that is, It is provided in the same interval as the through hole 4a of the healing pad 4.

使上述注入嘴12移動之注入嘴移動手段13係由如下構件所構成:X方向軌道21,其可與上述抽吸嘴移動手段11共通地使用;左右移動手段25,其沿著該X方向軌道21而移動;上下移動手段26,其設置於該左右移動手段25而使注入嘴12於Z方向升降;及上述培養容器支持部9中之上述Y方向平台9a。 The injection nozzle moving means 13 for moving the injection nozzle 12 is constituted by an X-direction rail 21 which can be used in common with the suction nozzle moving means 11 and a left-right movement means 25 along which the X-direction rail 21; moving; the vertical movement means 26 is provided in the left and right movement means 25 to raise and lower the injection nozzle 12 in the Z direction; and the Y-direction platform 9a in the culture container support portion 9.

再者,注入嘴12只要具備至少1根即可,又,注入嘴移動手段13亦可構成為不具備Y方向平台9a地使該注入嘴12於X方向及Y方向移動。 Further, the injection nozzle 12 may be provided with at least one of the injection nozzles, and the injection nozzle moving means 13 may be configured to move the injection nozzle 12 in the X direction and the Y direction without providing the Y-direction platform 9a.

又,亦可構成為具備多個注入嘴12且使其等個別地移動,藉此可將不同注入物注入。 Further, it is also possible to provide a plurality of injection nozzles 12 and to move them individually, whereby different injections can be injected.

上述X方向軌道21中,於在X方向移動之橫向移動手段27設置有照相機28,使該照相機28移動至培養容器支持部9之上方而拍攝培養容器3之內部。 In the X-direction track 21, a camera 28 is provided in the lateral movement means 27 that moves in the X direction, and the camera 28 is moved above the culture container support portion 9 to take the inside of the culture container 3.

於藉由上述抽吸嘴10使細胞凝集塊2保持於保持部H時,可利用上述照相機28拍攝所得之圖像,確認是否上述所有保持部H均已保持有細胞凝集塊2,視需要可下達指示來對未保持細胞凝集塊2之保持部H供給細胞凝集塊2。 When the cell aggregate 2 is held in the holding portion H by the suction nozzle 10, the image captured by the camera 28 can be used to confirm whether or not all of the holding portions H have the cell aggregate 2 held, if necessary. An instruction is given to supply the cell aggregate 2 to the holding portion H in which the cell aggregate 2 is not held.

進而,於藉由上述注入嘴12將注入物注入癒合墊4時,會利用上述照相機28拍攝所得之圖像,識別癒合墊4之貫通孔4a之位置。 Further, when the injection material is injected into the healing pad 4 by the injection nozzle 12, the image taken by the camera 28 is used to recognize the position of the through hole 4a of the healing pad 4.

又,於上述抽吸嘴移動手段11使抽吸嘴10位於培養容器支持部9之上方時、及注入嘴移動手段13使注入嘴12位於培養容器支持部9之上方時,照相機28會自 培養容器支持部9之上方退避以避免與其等接觸。 Further, when the suction nozzle moving means 11 is positioned above the culture container support portion 9 and the injection nozzle moving means 13 places the injection nozzle 12 above the culture container support portion 9, the camera 28 self-cultivates The upper side of the container support portion 9 is retracted to avoid contact with it.

以下,對使用具有上述構成之細胞之集合結構體之製作裝置1製作癒合墊4之方法進行說明。 Hereinafter, a method of producing the healing pad 4 using the manufacturing apparatus 1 having the aggregate structure of the cells having the above-described configuration will be described.

首先,進行準備步驟,即,經由上述傳遞窗5a而將收容有上述細胞凝集塊2之收容容器7或培養容器3搬入至上述隔離器5內,或向培養容器3供給特定量之培養液。 First, a preparation step is performed in which the storage container 7 or the culture container 3 in which the cell aggregate 2 is accommodated is carried into the isolator 5 via the transfer window 5a, or a specific amount of the culture solution is supplied to the culture container 3.

又,於培養容器3設置有由上述台座15及多個銷16所構成之培養保持器,又,上述支持板17藉由自體重量而位於與上述台座15之設置面15a接觸之下降位置。 Further, the culture container 3 is provided with a culture holder composed of the pedestal 15 and the plurality of pins 16, and the support plate 17 is placed at a lowered position in contact with the installation surface 15a of the pedestal 15 by its own weight.

進而,於準備步驟中,若將多個上述收容容器7或培養容器3搬入至隔離器5之內部,則能夠使用多個培養容器3連續地製作多個癒合墊4。 Further, in the preparation step, when a plurality of the storage containers 7 or the culture containers 3 are carried into the separator 5, a plurality of the healing pads 4 can be continuously produced using the plurality of culture containers 3.

於上述準備步驟完成後,繼而進行供給步驟,即,藉由上述抽吸嘴10使細胞凝集塊2自上述收容容器7向上述培養容器3移動,向藉由培養容器3之上述銷16而設定之保持部H供給細胞凝集塊2。 After the preparation step is completed, a supply step is performed in which the cell aggregate 2 is moved from the storage container 7 to the culture container 3 by the suction nozzle 10, and is set to the pin 16 of the culture container 3. The holding portion H is supplied to the cell aggregate 2 .

上述抽吸嘴移動手段11使抽吸嘴10移動,又,間隔變更手段24變更抽吸嘴10之間隔,然後於上述收容容器支持部8自收容容器7之收容凹部7a吸附保持細胞凝集塊2。 The suction nozzle moving means 11 moves the suction nozzle 10, and the interval changing means 24 changes the interval between the suction nozzles 10. Then, the storage container support portion 8 sucks and holds the cell aggregate 2 from the housing recess 7a of the storage container 7. .

繼而,抽吸嘴移動手段11使抽吸嘴10向培養容器支持部9移動,又,間隔變更手段24根據形成於上述銷16與銷16之間之保持部H之間隔而變更抽吸嘴10之間隔,然後使抽吸嘴10下降。 Then, the suction nozzle moving means 11 moves the suction nozzle 10 to the culture container support portion 9, and the interval changing means 24 changes the suction nozzle 10 in accordance with the interval between the holding portions H formed between the pin 16 and the pin 16. The interval is then lowered by the suction nozzle 10.

如此,則保持於抽吸嘴10之各細胞凝集塊2插入至形成於4根銷16之間之保持部H,從而以於細胞凝集塊2之下方形成間隙g之方式,將細胞凝集塊2保持於上述銷16之上下中間位置。 In this manner, the cell aggregates 2 held in the suction nozzle 10 are inserted into the holding portion H formed between the four pins 16, so that the cell agglomerates 2 are formed so as to form a gap g below the cell aggregate 2 It is held in the lower middle position above the above pin 16.

如此地使所有保持部H均保持細胞凝集塊2後,上述照相機28會移動至培養 容器支持部9之上方而拍攝培養容器3內之細胞凝集塊2,來確認細胞凝集塊2是否已配置於所需之保持部H。 When all the holding portions H are held in the cell aggregate 2 as described above, the camera 28 moves to the upper side of the culture container support portion 9 to photograph the cell aggregate 2 in the culture container 3, and confirms whether or not the cell aggregate 2 has been placed. The required holding portion H.

如此地將細胞凝集塊2配置於培養容器3內後,進行培養步驟,即,藉由機器人或作業員之手動作業,將上述培養容器3移送至培養箱6,而培養該培養容器3內之細胞凝集塊2。 After the cell aggregate 2 is placed in the culture container 3, the culture step is performed, that is, the culture container 3 is transferred to the incubator 6 by manual operation by a robot or a worker, and the culture container 3 is cultured. Cell agglutination block 2.

首先,將上述培養容器3移送至培養箱6之後,使培養箱6自上述隔離器5分離,而載置於與隔離器5離隔之位置,將內部維持為特定之溫度及濕度,並且維持特定之二氧化碳或氧之濃度。 First, after the culture container 3 is transferred to the incubator 6, the incubator 6 is separated from the isolator 5 and placed at a position separated from the isolator 5 to maintain the interior at a specific temperature and humidity, and maintain the specific The concentration of carbon dioxide or oxygen.

於培養容器3內,若培養細胞凝集塊2則鄰接之保持部H之細胞凝集塊2相互融合,藉此,可獲得作為細胞之集合結構體的癒合墊4,該作為細胞之集合結構體的癒合墊4維持了細胞凝集塊2平面性地配置之形狀。 In the culture container 3, when the cell aggregate 2 is cultured, the cell aggregates 2 adjacent to the holding portion H are fused to each other, whereby the healing pad 4 as a collection structure of cells can be obtained as the aggregate structure of the cells. The healing pad 4 maintains the shape in which the cell aggregate 2 is planarly arranged.

即,各細胞凝集塊2因移動受上述銷16限制,故可使所形成之癒合墊4之尺寸與最初配置細胞凝集塊2時之大小大致相同,從而能夠製作與配置細胞凝集塊2時相同的任意形狀之癒合墊4。 That is, since the movement of each cell aggregate 2 is restricted by the pin 16, the size of the formed healing pad 4 can be made substantially the same as the size when the cell aggregate 2 is initially placed, and the same can be made when the cell agglutination block 2 is placed. Healing pad 4 of any shape.

其原因在於,細胞凝集塊2以與其所接觸之上述銷16之周圍密接之方式增生或移動,而填充鄰接之細胞凝集塊2彼此之間所形成之間隙;如不經由銷16地將細胞凝集塊2平面性地配置而加以培養之情形般,整體上之尺寸幾乎不會縮小。 The reason for this is that the cell aggregate 2 is proliferated or moved in close contact with the periphery of the pin 16 in contact therewith, and fills the gap formed between the adjacent cell aggregates 2; if the cells are not agglutinated by the pin 16 As the block 2 is arranged in a planar manner and cultivated, the overall size is hardly reduced.

又,此時,由於上述細胞凝集塊2之下方形成有上述間隙g,故而可向癒合墊4與台座15之設置面15a之間供給培養液,而於癒合墊4之背面側亦有效率地進行培養。 Further, in this case, since the gap g is formed below the cell aggregate 2, the culture solution can be supplied between the healing pad 4 and the installation surface 15a of the pedestal 15, and the back surface side of the healing pad 4 can be efficiently used. Cultivate.

即,於使細胞凝集塊2載置於上述設置面15a而製作癒合墊4之情形時,存在培養液無法充分遍佈位於中央之細胞凝集塊2之下表面側之問題,但藉由將細胞凝集塊2以下方形成有間隙g之狀態加以保持,可使位於該部分之細胞亦被良好地培養。 In other words, when the cell aggregate 2 is placed on the installation surface 15a to form the healing pad 4, there is a problem that the culture solution cannot sufficiently spread over the lower surface side of the central cell agglomerate 2, but the cells are agglomerated. The state in which the gap g is formed below the block 2 is maintained, and the cells located in the portion are also well cultured.

再者,若於培養過程中使上述支持板17上下移動,則會促進培養液之流動而使效果更佳。 Further, if the support plate 17 is moved up and down during the culturing, the flow of the culture solution is promoted and the effect is further improved.

若如此地於上述培養步驟中一面更換培養液一面推進培養,則細胞凝集塊2彼此融合而可獲得所需大小之癒合墊4,但會形成癒合墊4保持於保持部H之狀態,換言之,形成上述銷16貫通癒合墊4之狀態。 When the culture medium is changed while the culture medium is being exchanged in the above-described culture step, the cell aggregates 2 are fused to each other to obtain the healing pad 4 of a desired size, but the healing pad 4 is held in the holding portion H, in other words, A state in which the above-mentioned pin 16 penetrates the healing pad 4 is formed.

因此,進行將保持於保持部H之癒合墊4自保持部H取出之脫離步驟。具體而言,將培養箱6連接於隔離器5且將培養容器3載置於隔離器5內部之上述培養容器支持部9,由作業員或機器人等使位於上述下降位置之支持板17位於上升位置。 Therefore, the detachment step of taking out the healing pad 4 held by the holding portion H from the holding portion H is performed. Specifically, the incubator 6 is connected to the isolator 5, and the culture container 3 is placed on the culture vessel support portion 9 inside the isolator 5, and the support plate 17 located at the descending position is raised by a worker or a robot or the like. position.

藉此,癒合墊4沿著銷16而上升,如圖4(b)所示,上述支持板17被提昇至上方,於該狀態下藉由夾具等固定件17b將上述支持板17固定,或使支持板17安靜地向下降位置移動,而藉由上述銷16之頂端部自下方支持癒合墊4,藉此使癒合墊4位於上述銷16之上方。 Thereby, the healing pad 4 is raised along the pin 16, and as shown in FIG. 4(b), the support plate 17 is lifted upward, and in this state, the support plate 17 is fixed by a fixing member 17b such as a jig, or The support plate 17 is moved quietly toward the lowered position, and the healing pad 4 is supported from below by the distal end portion of the pin 16, whereby the healing pad 4 is positioned above the pin 16.

於藉由上述脫離步驟使癒合墊4位於銷16之上方之後,繼而進行下述注入步驟,即,藉由上述注入嘴12將注入物注入開設於癒合墊4之藉由上述銷16而形成之貫通孔4a。 After the healing pad 4 is placed above the pin 16 by the above-described disengaging step, the following implantation step is performed, that is, the injection is injected into the healing pad 4 by the injection nozzle 12 to form the pin 16 Through hole 4a.

具體而言,首先上述照相機28移動至培養容器支持部9之上方並拍攝培養容器3內之癒合墊4,而識別該癒合墊4之貫通孔4a之位置。 Specifically, first, the camera 28 is moved above the culture container support portion 9 and the healing pad 4 in the culture container 3 is photographed, and the position of the through hole 4a of the healing pad 4 is recognized.

繼而,上述注入嘴移動手段13使注入嘴12向培養容器支持部9之上方移動,進而使之位於上述癒合墊4之貫通孔4a之上方之後,如圖6所示使該注入嘴12之注入部12b接近癒合墊4。 Then, the injection nozzle moving means 13 moves the injection nozzle 12 above the culture container support portion 9 so as to be positioned above the through hole 4a of the healing pad 4, and then injects the injection nozzle 12 as shown in FIG. The portion 12b is adjacent to the healing pad 4.

若於該狀態下自注入嘴12之注入部12b釋出注入物,則該注入物注入貫通孔4a之內部。 When the injection material is released from the injection portion 12b of the injection nozzle 12 in this state, the injection material is injected into the inside of the through hole 4a.

如此地將注入物注入癒合墊4之貫通孔4a後,為了直接使用癒合墊4,可將 其自培養容器3取出並移至搬出用之容器,而自隔離器5搬出,亦可將培養容器3再次自隔離器5移載至培養箱6繼續進行培養,而完全堵塞上述貫通孔4a。 After the injection material is injected into the through hole 4a of the healing pad 4 in this way, in order to directly use the healing pad 4, it can be taken out from the culture container 3 and moved to the container for carrying out, and can be carried out from the isolator 5, and the culture container can also be used. 3 is again transferred from the isolator 5 to the incubator 6 to continue the culture, and the through hole 4a is completely blocked.

圖7、8係說明作為第2實施例之細胞之集合結構體之製作方法的圖,於本實施例所使用之培養容器3中,固定於上述台座15之銷16係由保持癒合墊4之中央部之第1銷群(16a)與保持癒合墊4之外周緣部之以黑色表示之第2銷群(16b)所構成。 Figs. 7 and 8 are views showing a method of producing a collection structure of cells according to a second embodiment. In the culture container 3 used in the present embodiment, the pin 16 fixed to the pedestal 15 is held by the healing pad 4. The first pin group (16a) in the center portion and the second pin group (16b) which is black in the outer peripheral portion of the healing pad 4 are formed.

具體而言,於圖7中,構成上述第2銷群之銷16b配置為邊框狀,該邊框狀係將銷16b配置於最外周及較最外周往內一行而形成之形狀。因此,若於供給步驟中將細胞凝集塊2收容於培養容器3,則配置於其最外周之細胞凝集塊2保持於由上述第2銷群之銷16b所形成之保持部H。 Specifically, in FIG. 7, the pin 16b constituting the second pin group is arranged in a frame shape, and the frame shape is formed by arranging the pin 16b on the outermost circumference and the outermost circumference. Therefore, when the cell aggregate 2 is housed in the culture container 3 in the supply step, the cell aggregate 2 placed on the outermost periphery thereof is held by the holding portion H formed by the pin 16b of the second pin group.

又,如圖8所示,構成上述第1銷群之銷16a短於構成上述第2銷群之銷16b,且保持上述細胞凝集塊2之保持部H之高度設定為與上述第1銷群之銷16a之頂端部相近之高度。 Further, as shown in FIG. 8, the pin 16a constituting the first pin group is shorter than the pin 16b constituting the second pin group, and the height of the holding portion H holding the cell aggregate 2 is set to be the same as the first pin group. The height of the top end of the pin 16a is similar.

對使用上述培養容器3製作細胞之集合結構體之方法進行說明,如圖8(a)所示,於供給步驟中與上述第1實施例相同地,使由上述第1、第2銷群之銷16a、16b所形成之保持部H保持細胞凝集塊2。 A method of producing a collection structure of cells using the culture container 3 will be described. As shown in FIG. 8(a), in the supply step, the first and second pin groups are used in the same manner as in the first embodiment. The holding portion H formed by the pins 16a, 16b holds the cell aggregate 2 .

然後進行培養步驟,若細胞凝集塊2某種程度地融合而形成正在培養中之癒合墊4,則將收容有該所培養之癒合墊4之培養容器3自培養箱6向隔離器5移載。 Then, the culturing step is performed, and if the cell agglutination block 2 is fused to some extent to form the healing pad 4 being cultured, the culture container 3 containing the cultured healing pad 4 is transferred from the incubator 6 to the isolator 5. .

然後,如圖8(b)所示,進行脫離步驟,即,使位於下降位置之支持板17上下移動,使所培養之癒合墊4移動至與第2銷群之銷16b之頂端部相近之高度,然後將其自上述第1銷群之銷16a之保持部H取出。 Then, as shown in FIG. 8(b), the detaching step is performed, that is, the support plate 17 at the lowered position is moved up and down, and the cultured healing pad 4 is moved to be close to the tip end portion of the pin 16b of the second pin group. The height is then taken out from the holding portion H of the pin 16a of the first pin group.

藉此,形成癒合墊4由上述第2銷群之銷16b支持之狀態,於該癒合墊4開設出藉由第1銷群之銷16a而形成之貫通孔4a。 Thereby, the healing pad 4 is supported by the pin 16b of the second pin group, and the through hole 4a formed by the pin 16a of the first pin group is opened in the healing pad 4.

於該狀態下,進行注入步驟,即,藉由上述注入嘴12將注入物注 入癒合墊4之藉由第1銷群之銷16a而形成之貫通孔4a。 In this state, an injection step is performed in which the injection material is injected into the through hole 4a of the healing pad 4 by the pin 16a of the first pin group by the injection nozzle 12.

然後,使上述癒合墊4再次自隔離器5移動至培養箱6而再次開始培養步驟,繼續進行培養,藉此利用培養所得之細胞填充上述貫通孔4a。 Then, the healing pad 4 is again moved from the isolator 5 to the incubator 6 to restart the culturing step, and the culturing is continued, whereby the through-holes 4a are filled with the cells obtained by the culture.

此時,存在於堵塞貫通孔4a之過程中癒合墊4朝中央部收縮而彎曲之情形,但亦取決於貫通孔4a之大小。 At this time, the healing pad 4 is contracted and bent toward the center portion during the process of blocking the through hole 4a, but it also depends on the size of the through hole 4a.

針對此點,本實施例中係由上述第2銷群之銷16b保持癒合墊4之外周緣部,從而可獲得癒合墊4之中央部之收縮得到防止且無彎曲之厚度均勻的癒合墊4。 In this regard, in the present embodiment, the outer peripheral portion of the healing pad 4 is held by the pin 16b of the second pin group, so that the healing pad 4 in which the contraction of the central portion of the healing pad 4 is prevented and the thickness without bending is uniform can be obtained. .

若上述培養步驟結束,形成於上述癒合墊4之中央部之貫通孔4a被堵塞,則使上述培養容器3自培養箱6移動至隔離器5而進行脫離步驟。 When the above-described culturing step is completed, the through hole 4a formed in the central portion of the healing pad 4 is clogged, and the culture container 3 is moved from the incubator 6 to the isolator 5 to perform the detachment step.

具體而言,使上述支持板17再次自下降位置上升至上升位置,然後將癒合墊4自上述第2銷群之保持部H取出。 Specifically, the support plate 17 is again raised from the lowered position to the raised position, and then the healing pad 4 is taken out from the holding portion H of the second pin group.

由於在如此獲得之癒合墊4之外周緣部,形成有藉由之前始終進行貫通之上述第2銷群之銷16b而形成之貫通孔4a,故而可視需要將癒合墊4之外周緣部切斷而去除,僅回收中央部;亦可進而執行注入步驟,注入與藉由第1銷群之銷16a而形成之貫通孔4a不同之注入物。 Since the through hole 4a formed by the pin 16b of the second pin group that has been penetrated before is formed in the peripheral portion of the healing pad 4 thus obtained, the outer peripheral portion of the healing pad 4 can be cut as necessary. In addition, only the central portion is recovered, and the injection step may be further performed to inject an injection different from the through hole 4a formed by the pin 16a of the first pin group.

又,亦可不將注入物注入藉由第1銷群之銷16a而形成之貫通孔4a地將其堵塞,將注入物注入藉由第2銷群之銷16b而形成之貫通孔4a,亦可選擇性地配置第1銷群、第2銷群,設計注入物之注入位置。 Further, the injection material may be not inserted into the through hole 4a formed by the pin 16a of the first pin group, and the injection material may be injected into the through hole 4a formed by the pin 16b of the second pin group. The first pin group and the second pin group are selectively disposed, and the injection position of the implant is designed.

圖9係說明作為第3實施例之細胞之集合結構體之製作方法的圖,該實施例對應於如下情形,即細胞凝集塊2之直徑相較於保持部H之各對角位置之銷16之間隔為小徑,從而無法將該細胞凝集塊2保持於銷16與銷16之間。 Fig. 9 is a view for explaining a method of fabricating the aggregate structure of the cells of the third embodiment, which corresponds to a case where the diameter of the cell aggregate 2 is smaller than the pin 16 of each diagonal position of the holder H. The spacing is a small diameter so that the cell aggregate 2 cannot be held between the pin 16 and the pin 16.

具體而言,如圖10所示,為了使所製作之癒合墊4變薄,而設想使用極小之細胞凝集塊2之情形,或所製作出之細胞凝集塊2之大小存在差異,其中包含有未能保持於銷16與銷16之間而掉落之細胞凝集塊2之情形。 Specifically, as shown in FIG. 10, in order to make the healing pad 4 to be thinned, it is conceivable to use a very small cell aggregate 2, or the size of the produced cell agglomerate 2 varies, including The case of the cell aggregate 2 which was dropped between the pin 16 and the pin 16 was not maintained.

因此,於本實施例之供給步驟中,如圖9(a)所示,將銷16之間作為保持部H而收容細胞凝集塊2,並使其載置在位於上述台座15之設置面15a上之下降位置的支持板17之上表面,而保持各個細胞凝集塊2。 Therefore, in the supply step of the present embodiment, as shown in FIG. 9(a), the cell aggregate 2 is accommodated as the holding portion H between the pins 16, and is placed on the installation surface 15a of the pedestal 15. The upper surface of the support plate 17 is lowered in the upper position while the individual cell agglomerates 2 are held.

然後,於上述細胞凝集塊2載置於支持板17之狀態下,將該培養容器3移送至培養箱6開始上述培養步驟,如圖9(b)所示進行培養直至細胞凝集塊2融合為止。 Then, in a state where the cell aggregate 2 is placed on the support plate 17, the culture container 3 is transferred to the incubator 6 to start the above-described culturing step, and culture is carried out as shown in Fig. 9 (b) until the cell aggregate 2 is fused. .

於細胞凝集塊2一定程度地融合之後,使上述支持板17上升至上述銷16之基端側與頂端側之間之中間位置,將與豎立設置有上述多個銷16之設置面15a離隔之位置作為保持部H而保持細胞凝集塊2。 After the cell aggregate 2 is fused to a certain extent, the support plate 17 is raised to an intermediate position between the proximal end side and the distal end side of the pin 16, and is separated from the installation surface 15a on which the plurality of pins 16 are erected. The position as the holding portion H holds the cell aggregate 2 .

而且,於本實施例中,亦為於獲得特定大小之癒合墊4之後,自培養步驟過渡至脫離步驟及注入步驟。 Moreover, in the present embodiment, after the healing pad 4 of a certain size is obtained, the transition from the culture step to the detachment step and the injection step is performed.

圖11係說明作為第4實施例之細胞之集合結構體之製作方法的圖,與上述各實施例不同,豎立設置於培養容器3內之銷16之頂端形成得較為尖銳,從而係使銷16貫通細胞凝集塊2而加以保持。 Fig. 11 is a view for explaining a method of producing the aggregate structure of cells according to the fourth embodiment. Unlike the above-described respective embodiments, the tip end of the pin 16 which is erected in the culture container 3 is formed sharply so that the pin 16 is fastened. The cell aggregate 2 is passed through and held.

作為細胞之集合結構體之製作裝置1,可使用與上述各實施例中所使用之裝置相同者,但於藉由上述抽吸嘴10使上述銷16貫通上述細胞凝集塊2時,進行貫通之銷16會插入至上述抽吸部10b內,於特定位置使上述抽吸嘴10停止下降而保持細胞凝集塊2。 The apparatus 1 for producing a collection structure of cells can be the same as the apparatus used in each of the above embodiments, but when the pin 16 is passed through the cell aggregate 2 by the suction nozzle 10, it is penetrated. The pin 16 is inserted into the suction portion 10b, and the suction nozzle 10 is stopped at a specific position to hold the cell aggregate 2 .

於如此地保持細胞凝集塊2之情形時,亦為於上述培養步驟中鄰接之保持部H之細胞凝集塊2彼此融合,而可獲得與上述各實施例相同之癒合墊4。 When the cell aggregate 2 is held in this manner, the cell aggregates 2 adjacent to the holding portion H in the above-described culturing step are fused to each other, and the same healing pad 4 as in the above embodiments can be obtained.

又,於脫離步驟中,如圖11(b)所示,可使支持板17移動至上方位置,使細胞凝集塊2位於上述銷16之上方;於注入步驟中,可藉由上述注入嘴12將注入物注入各貫通孔4a。 Further, in the detaching step, as shown in FIG. 11(b), the support plate 17 can be moved to the upper position so that the cell aggregate 2 is positioned above the pin 16; in the injection step, the injection nozzle 12 can be used. The injection is injected into each of the through holes 4a.

再者,本實施例中,於被銷16貫通之位置形成有貫通孔4a,注入嘴12會移 動至該銷16之位置進行注入。 Further, in the present embodiment, the through hole 4a is formed at a position where the pin 16 penetrates, and the injection nozzle 12 is moved to the position of the pin 16 to be injected.

圖12係說明第5實施例之細胞之集合結構體之製作方法的圖,相對於上述第1~第4實施例中所製作出之作為細胞之集合結構體之平面性的癒合墊4,本實施例中係對在Z方向整齊排列有細胞凝集塊2之立體性的細胞之集合結構體之製作方法進行說明。 Fig. 12 is a view showing a method of producing a collection structure of cells according to a fifth embodiment, and a planar healing pad 4 as a collection structure of cells produced in the first to fourth embodiments, In the examples, a method of producing a collection structure of cells in which the cells of the cell agglutination block 2 are aligned in the Z direction will be described.

其中,於製作該立體性的細胞之集合結構體之情形時,亦可使用具有與上述第1實施例中所使用之細胞之集合結構體之製作裝置1相同之構成的裝置,又,可使用大致相同之步驟進行製作,故而關於詳細之說明將予以省略。 In the case of producing the aggregate structure of the three-dimensional cells, a device having the same configuration as the production device 1 of the aggregate structure of the cells used in the first embodiment may be used, and a device may be used. The steps are basically the same, and the detailed description will be omitted.

於圖12所示之本實施例所使用之培養容器3中,上述銷16之長度係根據所希望之立體性的細胞之集合結構體之高度而設定,能夠於由4根銷16所形成之保持部H沿Z方向保持多個細胞凝集塊2。 In the culture container 3 used in the present embodiment shown in Fig. 12, the length of the pin 16 is set according to the height of the desired three-dimensional aggregate structure of the cells, and can be formed by the four pins 16. The holding portion H holds a plurality of cell aggregates 2 in the Z direction.

而且,於上述供給步驟中,上述抽吸嘴10係基於預先設定之細胞凝集塊2之立體性的配置,而將上述細胞凝集塊2供給至由上述銷16所形成之保持部H。 Further, in the above-described supply step, the suction nozzle 10 supplies the cell aggregate 2 to the holding portion H formed by the pin 16 based on the three-dimensional arrangement of the cell agglomerates 2 set in advance.

具體而言,首先培養容器支持部9使培養容器3於Y方向依次移動,供給應配置於最下段之細胞凝集塊2,然後向保持於保持部H之細胞凝集塊2之上部依次供給細胞凝集塊2即可。 Specifically, first, the culture container holder 9 sequentially moves the culture container 3 in the Y direction, supplies the cell aggregate 2 to be placed in the lowermost stage, and sequentially supplies the cell agglutination to the upper portion of the cell aggregate 2 held in the holding portion H. Block 2 is OK.

此時,亦與上述各實施例相同地,在位於最下段之細胞凝集塊2之下方形成間隙g,藉此可向立體性的細胞之集合結構體之下表面供給培養液。又,在支持於上述銷16之立體性的細胞之集合結構體之側面部分與培養容器3之側面部分之間亦形成間隙,故而亦可向細胞之集合結構體之側面部分供給培養液,從而於培養步驟中可形成立體性的集合結構體。 At this time, as in the above-described respective embodiments, a gap g is formed below the cell aggregate 2 located at the lowermost stage, whereby the culture liquid can be supplied to the lower surface of the aggregate structure of the steric cells. Further, a gap is formed between the side portion of the aggregate structure of the cells supporting the three-dimensionality of the pin 16 and the side portion of the culture container 3, so that the culture liquid can be supplied to the side portion of the aggregate structure of the cells. A stereoscopic aggregate structure can be formed in the culturing step.

而且,於本實施例中,亦可藉由進行上述脫離步驟及上述注入步驟,而自上述注入嘴12將注入物注入自保持部H取出之集合結構體之貫通孔。於該情形時,亦可將上述注入嘴12插入至集合結構體之貫通孔,而將注入物注入該貫通 孔4a之上下方向之所需位置。 Further, in the present embodiment, the injection hole may be injected from the injection nozzle 12 into the through hole of the aggregate structure taken out from the holding portion H by performing the above-described detachment step and the above-described injection step. In this case, the injection nozzle 12 may be inserted into the through hole of the collecting structure, and the injection object may be injected into a desired position above the through hole 4a.

再者,於上述各實施例中,作為支持上述細胞凝集塊2之銷16之配置,只要能夠藉由多個銷16支持細胞凝集塊2即可,例如亦可配置為6根銷16圍繞各細胞凝集塊2。 Further, in each of the above embodiments, as the arrangement of the pins 16 for supporting the cell aggregate 2, the cell aggregate 2 can be supported by the plurality of pins 16, and for example, six pins 16 may be disposed around each other. Cell agglutination block 2.

於該情形時,上述保持部H配置為鋸齒狀,又,亦可使用該配置製作如上述第5實施例般之立體性的細胞之集合結構體。 In this case, the holding portion H is arranged in a zigzag shape, and a three-dimensional assembled structure of cells as in the fifth embodiment can be produced by using the arrangement.

進而,於上述各實施例中,根據設置於培養容器3之銷16之粗細、由銷16所形成之保持部H之大小、或所使用之細胞凝集塊2之直徑,如圖13所示可考慮各種態樣。 Further, in each of the above embodiments, the thickness of the pin 16 provided in the culture container 3, the size of the holding portion H formed by the pin 16, or the diameter of the cell aggregate 2 to be used may be as shown in FIG. Consider a variety of aspects.

圖示出了如下情形:即便圖13所示之銷16之直徑相較於上述各實施例中所示之銷16之直徑為大徑,且細胞凝集塊2之直徑大於對角位置之2根銷16之間隔,保持於上述保持部H之鄰接之細胞凝集塊2彼此亦不會接觸。 The figure shows a case where the diameter of the pin 16 shown in Fig. 13 is larger than the diameter of the pin 16 shown in each of the above embodiments, and the diameter of the cell aggregate 2 is larger than 2 of the diagonal position. At the interval of the pins 16, the cell aggregates 2 adjacent to each other held by the holding portion H are not in contact with each other.

於此種情形時,亦為於上述培養步驟中培養細胞凝集塊2從而鄰接之細胞凝集塊2融合,故而可獲得如上所述之癒合墊4,又,由於銷16係大徑,故而形成於癒合墊4之貫通孔4a亦成為大徑,故而能夠將注入物大量注入該貫通孔4a之內部,亦能夠藉由銷16之粗細而規定注入量。 In this case, the cell aggregate 2 is also cultured in the above-described culture step so that the adjacent cell aggregate 2 is fused, so that the healing pad 4 as described above can be obtained, and since the pin 16 is large in diameter, it is formed in Since the through hole 4a of the healing pad 4 also has a large diameter, it is possible to inject a large amount of the injection into the inside of the through hole 4a, and the injection amount can be specified by the thickness of the pin 16.

於將營養成分、成長因子、增生因子或藥物等作為注入物注入形成於上述癒合墊4之貫通孔4a之情形時,亦可根據該等注入物之作用,例如每隔一個貫通孔4a地進行注入,以使效果分散,又,亦可考慮僅將注入物注入至癒合墊4之集中於特定位置之貫通孔4a,以使癒合墊4之特定位置具有作用性。 When a nutrient component, a growth factor, a proliferative factor, a drug, or the like is injected as an injection into the through hole 4a formed in the healing pad 4, it may be performed according to the action of the implant, for example, every other through hole 4a. The injection is performed to disperse the effect, and it is also conceivable to inject only the injection into the through hole 4a of the healing pad 4 concentrated at a specific position to make the specific position of the healing pad 4 effective.

又,亦可將包含構成血管之細胞之細胞懸濁液作為注入物選擇性地注入貫通孔4a,以於癒合墊4之所需部分形成血管;亦可根據癒合墊4之用途,而選擇貫通孔4a之位置將不同種類之注入物注入。 Further, the cell suspension containing the cells constituting the blood vessel may be selectively injected as an infusion into the through hole 4a to form a blood vessel at a desired portion of the healing pad 4, or may be selected according to the use of the healing pad 4. The location of the holes 4a injects different types of implants.

Claims (6)

一種細胞之集合結構體之製作方法,其將多個細胞凝集塊配置於收容有培養液之培養容器之內部,培養上述多個細胞凝集塊,而製作由上述多個細胞凝集塊相互融合而成的細胞之集合結構體;且其特徵在於具有:供給步驟,其使由豎立設置於上述培養容器之內部之多個銷所構成的保持部保持細胞凝集塊;培養步驟,其培養保持於上述保持部之細胞凝集塊而形成上述集合結構體;脫離步驟,其將於該培養步驟中形成之集合結構體自上述保持部取出;及注入步驟,其將注入物注入開設於該脫離步驟中所取出之集合結構體之藉由上述銷而形成的貫通孔。  A method for producing a collection structure of cells, wherein a plurality of cell aggregates are disposed in a culture container in which a culture solution is accommodated, and the plurality of cell aggregates are cultured, and the plurality of cell aggregates are fused together a collection structure of cells; and characterized by: a supply step of holding a cell aggregate by a holding portion composed of a plurality of pins erected inside the culture container; and a culture step of maintaining the culture in the above-mentioned retention a cell agglutinating block to form the aggregate structure; a detaching step of taking out the aggregate structure formed in the culturing step from the holding portion; and an injecting step of injecting the implant into the detaching step The through hole formed by the pin is formed in the aggregate structure.   如請求項1所述之細胞之集合結構體之製作方法,其中,於上述注入步驟之後,繼續培養上述集合結構體。  The method for producing a collection structure of cells according to claim 1, wherein the collection structure is further cultured after the injection step.   一種細胞之集合結構體之製作裝置,其將多個細胞凝集塊配置於收容有培養液之培養容器之內部,培養上述多個細胞凝集塊,而製作由上述多個細胞凝集塊相互融合而成的細胞之集合結構體;且其特徵在於具備:培養保持器,其設置於上述培養容器之內部,且豎立設置有多個銷;供給手段,其使由上述培養保持器之銷所構成之多個保持部保持細胞凝集塊;脫離手段,其將對保持於上述培養保持器之細胞凝集塊加以培養而形成之集合結構體自上述培養保持器之上述保持部取出;及注入手段,其將注入物注入開設於該已取出之集合結構體之藉由上述銷而形成的貫通孔。  An apparatus for producing a collection structure of cells, wherein a plurality of cell aggregates are placed inside a culture container in which a culture solution is accommodated, and the plurality of cell aggregates are cultured, and the plurality of cell aggregates are fused together a collection structure of cells; and characterized in that: a culture holder provided inside the culture container and provided with a plurality of pins erected; and a supply means for constituting the plurality of pins of the culture holder Each of the holding portions holds a cell aggregate; the detaching means takes out the aggregate structure formed by culturing the cell aggregates held in the culture holder from the holding portion of the culture holder; and the injection means, which is injected The object is injected into a through hole formed in the removed aggregate structure by the pin.   如請求項3所述之細胞之集合結構體之製作裝置,其中,上述培養保持器之保持部形成於上述多個銷與銷之間,上述供給手段使銷與銷之間夾持或收容細胞凝集塊。  The apparatus for producing a collection structure of cells according to claim 3, wherein the holding portion of the culture holder is formed between the plurality of pins and the pin, and the supply means sandwiches or houses the cells between the pin and the pin. Agglutination block.   如請求項3所述之細胞之集合結構體之製作裝置,其中,上述培養保持器之保持部係由頂端形成得較為尖銳之上述銷所構成,上述供給手段使 上述銷貫通上述細胞凝集塊,並且使上述細胞凝集塊停止於該銷之特定位置。  The apparatus for producing a collection structure of cells according to claim 3, wherein the holding portion of the culture holder is constituted by the pin whose tip end is sharply formed, and the supply means causes the pin to pass through the cell aggregate. And stopping the cell agglutination block at a specific position of the pin.   如請求項3至5中任一項所述之細胞之集合結構體之製作裝置,其中,上述脫離手段具備能夠沿著上述培養保持器之銷而移動之支持構件,於上述供給手段使保持部保持細胞凝集塊時,該支持構件位於銷之基端側,於將細胞凝集塊融合而形成之集合結構體自保持部取出時,該支持構件位於銷之頂端側。  The apparatus for producing a collection structure of cells according to any one of claims 3 to 5, wherein the separation means includes a support member movable along a pin of the culture holder, and the holding means is provided by the supply means When the cell aggregate is held, the support member is located on the proximal end side of the pin, and when the aggregate structure formed by fusing the cell aggregate is taken out from the holding portion, the support member is located on the distal end side of the pin.  
TW106136724A 2016-12-05 2017-10-25 Method and apparatus both for producing cell aggregate structure TW201831676A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016236183A JP6889363B2 (en) 2016-12-05 2016-12-05 Method and apparatus for preparing a cell aggregate structure
JPJP2016-236183 2016-12-05

Publications (1)

Publication Number Publication Date
TW201831676A true TW201831676A (en) 2018-09-01

Family

ID=62491880

Family Applications (1)

Application Number Title Priority Date Filing Date
TW106136724A TW201831676A (en) 2016-12-05 2017-10-25 Method and apparatus both for producing cell aggregate structure

Country Status (3)

Country Link
JP (1) JP6889363B2 (en)
TW (1) TW201831676A (en)
WO (1) WO2018105255A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130910B1 (en) * 2007-03-30 2016-10-19 Kyushu University, National University Corporation Method for production of three-dimensional structure of cells
KR20170020942A (en) * 2008-06-24 2017-02-24 더 큐레이터스 오브 더 유니버시티 오브 미주리 Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same
JP5896104B2 (en) * 2011-06-24 2016-03-30 国立大学法人佐賀大学 Three-dimensional structure manufacturing apparatus for cells
US9442105B2 (en) * 2013-03-15 2016-09-13 Organovo, Inc. Engineered liver tissues, arrays thereof, and methods of making the same
WO2016046938A1 (en) * 2014-09-25 2016-03-31 株式会社サイフューズ Cell tray and device, method and system for producing cell structure
JP6534269B2 (en) * 2015-03-18 2019-06-26 富士フイルム株式会社 Tubular structure, method of producing cell structure, and method of producing tubular structure
JP6882658B2 (en) * 2015-10-29 2021-06-02 澁谷工業株式会社 Method and apparatus for preparing a cell aggregate structure

Also Published As

Publication number Publication date
JP2018088879A (en) 2018-06-14
JP6889363B2 (en) 2021-06-18
WO2018105255A1 (en) 2018-06-14

Similar Documents

Publication Publication Date Title
JP6882658B2 (en) Method and apparatus for preparing a cell aggregate structure
JP5757961B2 (en) Bioprinting station, assembly including the bioprinting station, and bioprinting method
JP2016093149A (en) Cell culture apparatus, and cell culture method
JP7102734B2 (en) Cell culture method and equipment
KR20170003918A (en) Methods, devices, and systems for the fabrication of materials and tissues utilizing electromagnetic radiation
CN107320773B (en) Artificial muscle scaffold model and preparation device and method thereof
CA2818514A1 (en) Bioreactors, systems, and methods for producing and/or analyzing organs
ES2766199T3 (en) Frame for tissue growth in vivo
Zarkesh et al. Synthetic developmental biology: Engineering approaches to guide multicellular organization
EP3162890A1 (en) Method and apparatus for producing cell mass structure
TW201718847A (en) Apparatus for producing cell mass sheet and method for producing cell mass sheet
CN113846016B (en) High-flux porous array chip, device, preparation method and application
KR101341572B1 (en) 3-dimensional cell culture instrument using hollow tube and 3-dimensional cell culture method using the same
TW201831676A (en) Method and apparatus both for producing cell aggregate structure
JP6382938B2 (en) Cell culture jig and cell culture method using the cell culture jig
KR101095616B1 (en) A system for manufacturing regeneration of a three dimensional tissue
KR101585328B1 (en) Hybrid Bio Print Apparatus for manufacturing Scaffold Supporter and Method for manufacturing using the same
CN114259601B (en) Living cell bionic cornea anterior lamina and preparation method thereof
CN105420105B (en) Biochip and its manufacture method
WO2022059777A1 (en) Three-dimensional artificial tissue manufacturing apparatus and three-dimensional artificial tissue manufacturing method
DE19808055A1 (en) Tissue engineering procedure extracting and culturing cells with mechanical stimulation to simulate in-vivo growth
JP7037038B2 (en) Equipment for making a cell aggregate structure
JP6982231B2 (en) Equipment for making a cell aggregate structure
CN114958725B (en) Three-dimensional cell sphere hanging drop culture and co-culture method based on hydrophilic-hydrophobic array chip
JP7041346B2 (en) Cell culture method using gelatin support